RBE variation in prostate carcinoma cells in active scanning proton beams: In-vitro measurements in comparison with phenomenological models
Authors:
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Physica Medica
- Vol. 77, 187-193
Abstract
No abstract availableKeywords
Funding Information
- Federal Ministry for Digital and Economic Affairs
This publication has 42 references indexed in Scilit:
- Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liverPhysics in Medicine & Biology, 2013
- Range uncertainty in proton therapy due to variable biological effectivenessPhysics in Medicine & Biology, 2012
- Enhanced relative biological effectiveness of proton radiotherapy in tumor cells with internalized gold nanoparticlesApplied Physics Letters, 2011
- Dose- and LET-painting with particle therapyActa Oncologica, 2010
- Use of Individual Fraction Size Data from 3756 Patients to Directly Determine the α/β Ratio of Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- The incorporation of the concept of minimum RBE (RBEmin) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatmentsInternational Journal of Radiation Biology, 2007
- The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancerPhysics in Medicine & Biology, 2005
- The radiobiology of prostate cancer including new aspects of fractionated radiotherapyActa Oncologica, 2005
- Comparison ofin vitroandin vivo / ratios for prostate cancerPhysics in Medicine & Biology, 2004
- Is the prostate α/β ratio of 1.5 from Brenner & Hall a modeling artifact?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000